The global Rapid Medical Diagnostic Kits market, valued at $28.11 billion in 2025, is projected to grow to $67 billion by 2035 at a CAGR of 9.06%. Growth is fueled by increasing infectious and chronic diseases, technological innovations like AI and biosensors, and rising consumer demand for home testing. North America leads with 37% market share, while Asia Pacific is the fastest-growing region. The market benefits from government support, expanding point-of-care diagnostics, and digital health integration, with key players including Abbott and Roche driving innovation.

More News (ABT)

Abbott Laboratories upgraded to Buy ahead of Q2 2026 earnings on growth from Exact Sciences acquisition

Abbott Laboratories has been upgraded to Buy ahead of its Q2 2026 earnings report, following a period of share price decline exceeding 20%. The recent acquisition of Exact Sciences is expected to add a high-growth cancer diagnostics segment, targetin...

Company Fundamentals

Bullish

2 days ago

Rapid Medical Diagnostic Kits market to reach $67B by 2035, driven by tech advances and rising disease testing demand.

More News (ABT)

Abbott Laboratories upgraded to Buy ahead of Q2 2026 earnings on growth from Exact Sciences acquisition

Invest & Trade with
#1 Award-Winning Investment Super App

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store

Rapid Medical Diagnostic Kits market to reach $67B by 2035, driven by tech advances and rising disease testing demand.

More News (ABT)

Abbott Laboratories upgraded to Buy ahead of Q2 2026 earnings on growth from Exact Sciences acquisition

Invest & Trade with#1 Award-Winning Investment Super App

iOS App Store

Google Play Store

Invest & Trade with
#1 Award-Winning Investment Super App